166 related articles for article (PubMed ID: 22763801)
1. Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.
Punzi HA; Lewin A; Li W; Chavanu KJ
Adv Ther; 2012 Jun; 29(6):524-37. PubMed ID: 22763801
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension.
Weir MR; Punzi HA; Flack JM; Stoakes KA; Chavanu KJ; Li W; Dubiel R
Postgrad Med; 2011 Jan; 123(1):80-7. PubMed ID: 21293087
[TBL] [Abstract][Full Text] [Related]
3. Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertension.
Flack JM; Graff A; Li W; Chavanu KJ
Postgrad Med; 2012 May; 124(3):59-70. PubMed ID: 22691900
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
Hsueh WA; Shojaee A; Maa JF; Neutel JM
Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
7. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
8. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
Oparil S; Lee J; Karki S; Melino M
J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Chrysant SG; Weber MA; Wang AC; Hinman DJ
Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
Germino FW; Neutel JM; Dubiel R; Maa JF; Chavanu KJ
Am J Cardiovasc Drugs; 2012 Oct; 12(5):325-33. PubMed ID: 22920048
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of olmesartan medoxomil versus losartan potassium in Chinese patients with mild to moderate essential hypertension].
Zhu JR; Cai NS; Fan WH; Zhu DL; He B; Wu ZG; Ke YN; Guo JX; Ma H; Huang J; Li XL; Chen YZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):877-81. PubMed ID: 17217710
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
Ram CV
Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.
Zhu JR; Zhang SY; Gao PJ
Arch Pharm Res; 2014 Dec; 37(12):1588-98. PubMed ID: 25060946
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Punzi H; Shojaee A; Maa JF;
Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):149-61. PubMed ID: 22855062
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.
Chrysant SG
Clin Drug Investig; 2010; 30(7):473-82. PubMed ID: 20528002
[TBL] [Abstract][Full Text] [Related]
19. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
Rump LC; Girerd X; Sellin L; Stegbauer J
J Hum Hypertens; 2011 Sep; 25(9):565-74. PubMed ID: 21107435
[TBL] [Abstract][Full Text] [Related]
20. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
